Capricor Therapeutics CAPR Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's operating lease right-of-use assets in other assets?
- Capricor Therapeutics (CAPR) reported operating lease right-of-use assets in other assets of $13.16M in Q1 2026.
- How has Capricor Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
- Capricor Therapeutics's operating lease right-of-use assets in other assets increased by 1066.8% year-over-year, from $1.13M to $13.16M.